Author Contributions: Dr Kistorp had full access
to all of the data in the study and takes responsibility for the integrity
of the data and the accuracy of the data analysis.
Study concept and design: Kistorp, Raymond,
Acquisition of data: Kistorp, Raymond, Pedersen,
Analysis and interpretation of data: Kistorp,
Raymond, Gustafsson, Faber, Hildebrandt.
Drafting of the manuscript: Kistorp, Faber.
Critical revision of the manuscript for important
intellectual content: Raymond, Pedersen, Gustafsson, Faber, Hildebrandt.
Statistical analysis: Kistorp, Gustafsson.
Obtained funding: Kistorp, Raymond.
Administrative, technical, or material support:
Raymond, Pedersen, Faber, Hildebrandt.
Study supervision: Raymond, Faber, Hildebrandt.
Financial Disclosures: Dr Hildebrandt receives
honoraria for being on the advisory board and lectures from Roche Diagnostics.
No other authors reported financial disclosures.
Funding/Support: This study was supported by
grant 10/02S from the Copenhagen Hospital Corporation, Copenhagen, Denmark
(Dr Kistorp). Roche Diagnostics, Mannheim, Germany, provided the measurements
of plasma NT-proBNP and C-reactive protein for the study.
Role of the Sponsor: The Copenhagen Hospital
Corporation and Roche Diagnostics had no role in the design or conduct of
the study, no involvement in the management, analysis, and interpretation
of the data, and did not review or approve the manuscript.